Tirzepatide 40mg
$249.00
40mg
Dual Agonist
Metabolic peptide
GLP-1 · GIP
CAS 2023788-19-2
UK Dispatch
Discreet Packaging
Description
Tirzepatide 40mg
Metabolic Peptide · Dual Agonist · GLP-1 · GIP
Tirzepatide 40mg is a metabolic peptide
characterised by dual receptor agonist activity involving
GLP-1 and GIP.
This 40mg formulation provides a clearly specified quantity of
Tirzepatide together with detailed compound identification,
making it a straightforward option for customers looking for
Tirzepatide 40mg with a defined dual-pathway
receptor profile.
40mg
GLP-1 · GIP
40mg
2023788-19-2
Tirzepatide 40mg
Tirzepatide 40mg
Dual agonist · GLP-1 · GIP
Quantity
Tirzepatide is characterised by activity
across two receptor pathways:
GLP-1 and GIP.
This dual receptor profile is the defining characteristic
of Tirzepatide.
The 40mg formulation provides a clearly defined quantity
of Tirzepatide for customers seeking a higher-quantity
formulation with detailed compound identification.
Dual Agonist Profile
01
02
About Tirzepatide 40mg
Tirzepatide 40mg is a metabolic peptide
distinguished by its dual receptor profile involving
GLP-1 and GIP.
GLP-1 refers to
glucagon-like peptide-1, while GIP refers
to glucose-dependent insulinotropic polypeptide.
Tirzepatide is designed around activity at both of these
receptor pathways.
This combination is commonly described as a
dual agonist, distinguishing Tirzepatide
from compounds that act primarily through a single receptor
pathway.
The MetaTide Health 40mg formulation provides a defined
quantity together with key compound identification,
including the CAS number and molecular formula.
Tirzepatide 40mg Specifications
40mg
2
Metabolic Peptide
SCIENTIFIC OVERVIEW
Tirzepatide & Dual Receptor Activity
Tirzepatide is characterised by activity involving two
receptor pathways: GLP-1 and GIP.
This two-pathway profile is the defining characteristic
behind the term dual agonist.
The GLP-1 pathway is associated with the
glucagon-like peptide-1 receptor, while the
GIP pathway relates to the
glucose-dependent insulinotropic polypeptide receptor.
These receptor pathways are relevant to scientific research
involving metabolic signalling, glucose regulation, energy
balance and related biological processes.
The 40mg formulation provides a clearly identified quantity
of Tirzepatide with the corresponding CAS number and molecular
formula supplied for product identification.
Product Information
Compound Identification
Tirzepatide is identified by its compound name,
40mg quantity and CAS number 2023788-19-2.
Molecular Information
The supplied molecular formula for Tirzepatide 40mg
is C225H348N48O68.
Dual Agonist Profile
The product is characterised by its GLP-1 and GIP
receptor profile.
Frequently Asked Questions
What is Tirzepatide 40mg?
+
Tirzepatide 40mg is a metabolic peptide formulation
characterised by dual agonist activity involving
GLP-1 and GIP receptor pathways.
What does dual agonist mean?
+
Dual agonist refers to Tirzepatide’s activity across
two receptor pathways: GLP-1 and GIP.
What are the two pathways associated with Tirzepatide?
+
The two pathways are GLP-1 and GIP. GLP-1 refers to
glucagon-like peptide-1, while GIP refers to
glucose-dependent insulinotropic polypeptide.
How much Tirzepatide is included?
+
This formulation contains 40mg of Tirzepatide.
What is the CAS number for Tirzepatide?
+
The CAS number provided for Tirzepatide is
2023788-19-2.
What is the molecular formula?
+
The molecular formula provided for Tirzepatide is
C225H348N48O68.
What is the receptor profile of Tirzepatide?
+
Tirzepatide is characterised by a dual receptor
agonist profile involving GLP-1 and GIP.
Research-Only Information
This product is supplied strictly for
laboratory research purposes.
Information presented on this page describes the product and
relevant research context and does not constitute medical,
therapeutic, diagnostic or treatment advice.
For Laboratory Research Use Only
Not for human or veterinary diagnostic or therapeutic use.
This material is intended exclusively for controlled
laboratory research by appropriately qualified personnel.
It is not intended for human consumption, self-administration,
diagnosis, treatment or prevention of disease.
TIRZEPATIDE 40MG
MetaTide Health Metabolic Peptide
Dual Agonist · GLP-1 · GIP
TIRZEPATIDE
Reviews
There are no reviews yet.